Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 41Stomach Neoplasms 22Esophageal Neoplasms 20Esophageal Squamous Cell Carcinoma 19Colorectal Neoplasms 12Pancreatic Neoplasms 9Liver Neoplasms 6Cholangiocarcinoma 6Biliary Tract Neoplasms 5Advanced Gastric Cancer 5Locally Advanced Gastric Cancer 4Rectal Neoplasms 3Neoplasms 2Neoplasm Metastasis 2Metastatic Gastric Adenocarcinoma 2Locally Advanced Rectal Cancer 2Liver Diseases 2Gastrointestinal Neoplasms 2Esophageal Diseases 2Digestive System Neoplasms 2Colonic Neoplasms 2Advanced Gastric Adenocarcinoma 2Unresectable Gallbladder Cancer 1Turcot syndrome 1Stomach Diseases 1Stage IV Gastric Cancer With Metastasis 1Second Line Treatment of Gastric Cancer 1SHR-1210 1Recurrence 1Rectal Cancer Patients 1

Interventions

Capecitabine 20Oxaliplatin 13Irinotecan 8spartalizumab 6tislelizumab 4Radiation 4Neoadjuvant Therapy 4Immune Checkpoint Inhibitors 4Fluorouracil 4toripalimab 3sintilimab 2camrelizumab 2Radiotherapy 2Leucovorin 2Celecoxib 2veliparib 1peposertib 1nimotuzumab 1irinotecan sucrosofate 1XELOX 1Thymalfasin 1Radiotherapy, Intensity-Modulated 1Injections 1HMPL-013 1Folfox protocol 1Diathermy 1Combined Modality Therapy 1Chemoradiotherapy 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Locally Advanced Rectal Cancer × camrelizumab × Gastrointestinal × Clear all
NCT07527026 2026-04-14

A Single-arm Phase II Clinical Study of Camrelizumab Combined With Long-course Chemoradiotherapy for Total Neoadjuvant Therapy in Locally Advanced Low pMMR/MSS Rectal Cancer

Chinese PLA General Hospital

Phase 2 Recruiting
44 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT07057089 2025-08-14

Involved-field Radiotherapy-TNT Combined With PD-1 Inhibitor for pMMR Locally Advanced Rectal Cancer (Neo-Field I)

Hebei Medical University Fourth Hospital

Phase 2 Recruiting
90 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡